课题基金 / 基金详情

Graduate Training in Stem Cell Biology and Regenerative Medicine

Graduate Training in Stem Cell Biology and Regenerative Medicine
干细胞生物学和再生医学研究生培训
批准号:
10208896
负责人:
IRVING L. WEISSMAN
金额:
$48.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-06-30

项目摘要

项目成果

IRVING L. WEISSMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY This new T32 application seeks support for predoctoral training in the newly established doctoral degree program in Stem Cell Biology and Regenerative Medicine (SCBRM) at Stanford University. The SCBRM graduate program is the first new doctoral degree program at the School of Medicine in more than 20 years. The program faculty span multiple schools and departments at Stanford and our primary goal is to train the best scientists in this new discipline through a combination of basic stem cell biology and the role of stem cells in the development, maintenance, and disease pathogenesis of human tissues and organs. Over the last decade, fundamental discoveries in the biomedical and physical sciences have generated a strong climate of expectation that discoveries should and will lead to new medical applications and novel therapies. There is no greater expectation than that produced within the broad discipline of stem cell biology and regenerative medicine, an established area of study that rests squarely on an unprecedented intersection of disciplines. On the one hand, rapid advances in basic biology, genetics, material sciences, nanotechnology, engineering, and physics are providing extraordinary new tools for harnessing stem cells in regenerative medicine. On the other hand, rapid and continued growth of financial investment in translational medicine by national, state, and private entities targets research dollars with an increasing focus on applied science. Research in stem cell biology and regenerative medicine also raises ethical and legal concerns that are unique in all of biological research; thus, this broad intersection of disciplines is producing a new breed of scientist, one with skills that embrace biological and physical sciences, medicine, business, ethics and law. In the following application we outline a novel predoctoral curriculum and training plan that provides a strong foundation in developmental and cellular biology, genetics, and biochemistry. These intellectual strengths are partnered with clinical science, bioengineering, business, ethics and law to produce a new generation of scientist who is both motivated and capable of translating stem cell discoveries into new applications in regenerative medicine.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.omtn.2018.04.017
发表时间: 2018-09-07
期刊: Molecular therapy. Nucleic acids
影响因子: --
作者: [Charlesworth CT, Camarena J, Cromer MK, Vaidyanathan S, Bak RO, Carte JM, Potter J, Dever DP, Porteus MH]
通讯作者: Porteus MH
Single amino acid mutations in the Saccharomyces cerevisiae rhomboid peptidase, Pcp1p, alter mitochondrial morphology.
酿酒酵母菱形肽酶 Pcp1p 中的单氨基酸突变会改变线粒体形态。
DOI: 10.1002/cbin.11219
发表时间: 2020
期刊: Cell biology international
影响因子: 3.9
作者: [Huddleston,MaryElizabeth, Xiao,Ningyu, Both,AndriesPieter, Gordon,DonnaM]
通讯作者: Gordon,DonnaM
DOI: 10.1073/pnas.2318534121
发表时间: 2024-01
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [A. Banuelos;Allison Zhang;Hala Berouti;Michelle Baez;Leyla Yılmaz;Nardin Georgeos;Kristopher D Marjon-Kristop]
通讯作者: A. Banuelos;Allison Zhang;Hala Berouti;Michelle Baez;Leyla Yılmaz;Nardin Georgeos;Kristopher D Marjon-Kristop
NexTGen - STANFORD
  • 批准号:
    10625700
  • 项目类别:
  • 资助金额:
    $73.05万
  • 财政年份:
    2022
  • 负责人:
    IRVING L. WEISSMAN
  • 依托单位:
Programmed Cell Removal (PrCR) by Macrophages: recognition and phagocytosis of target cells
  • 批准号:
    10576906
  • 项目类别:
  • 资助金额:
    $40.47万
  • 财政年份:
    2020
  • 负责人:
    IRVING L. WEISSMAN
  • 依托单位:
Programmed Cell Removal (PrCR) by Macrophages: recognition and phagocytosis of target cells
  • 批准号:
    10092925
  • 项目类别:
  • 资助金额:
    $40.47万
  • 财政年份:
    2020
  • 负责人:
    IRVING L. WEISSMAN
  • 依托单位:
Programmed Cell Removal (PrCR) by Macrophages: recognition and phagocytosis of target cells
  • 批准号:
    9888242
  • 项目类别:
  • 资助金额:
    $40.47万
  • 财政年份:
    2020
  • 负责人:
    IRVING L. WEISSMAN
  • 依托单位:
海外基金